Surgery for Malignancy
| MS-DRGs are grouped by "Medical Service" to provide a meaningful way of summarizing utilization data. MS-DRGs are based on FY 2011 regulations. |
|
| MS-DRG | MS-DRG Description |
| 582 | Mastectomy for malignancy w CC/MCC |
| 583 | Mastectomy for malignancy w/o CC/MCC |
| 656 | Kidney & ureter procedures for neoplasm w MCC |
| 657 | Kidney & ureter procedures for neoplasm w CC |
| 658 | Kidney & ureter procedures for neoplasm w/o CC/MCC |
| 707 | Major male pelvic procedures w CC/MCC |
| 708 | Major male pelvic procedures w/o CC/MCC |
| 715 | Other male reproductive system O.R. proc for malignancy w CC/MCC |
| 716 | Other male reproductive system O.R. proc for malignancy w/o CC/MCC |
| 734 | Pelvic evisceration, rad hysterectomy & rad vulvectomy w CC/MCC |
| 735 | Pelvic evisceration, rad hysterectomy & rad vulvectomy w/o CC/MCC |
| 736 | Uterine & adnexa proc for ovarian or adnexal malignancy w MCC |
| 737 | Uterine & adnexa proc for ovarian or adnexal malignancy w CC |
| 738 | Uterine & adnexa proc for ovarian or adnexal malignancy w/o CC/MCC |
| 739 | Uterine,adnexa proc for non-ovarian/adnexal malig w MCC |
| 740 | Uterine,adnexa proc for non-ovarian/adnexal malig w CC |
| 741 | Uterine,adnexa proc for non-ovarian/adnexal malig w/o CC/MCC |
| 820 | Lymphoma & leukemia w major O.R. procedure w MCC |
| 821 | Lymphoma & leukemia w major O.R. procedure w CC |
| 822 | Lymphoma & leukemia w major O.R. procedure w/o CC/MCC |
| 823 | Lymphoma & non-acute leukemia w other O.R. proc w MCC |
| 824 | Lymphoma & non-acute leukemia w other O.R. proc w CC |
| 825 | Lymphoma & non-acute leukemia w other O.R. proc w/o CC/MCC |
| 826 | Myeloprolif disord or poorly diff neopl w maj O.R. proc w MCC |
| 827 | Myeloprolif disord or poorly diff neopl w maj O.R. proc w CC |
| 828 | Myeloprolif disord or poorly diff neopl w maj O.R. proc w/o CC/MCC |
| 829 | Myeloprolif disord or poorly diff neopl w other O.R. proc w CC/MCC |
| 830 | Myeloprolif disord or poorly diff neopl w other O.R. proc w/o CC/MCC |